Article Details

Tonix Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights

Retrieved on: 2021-05-10 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Tonix Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights. View article details on hiswai:

Excerpt

TNX-1500 (anti-CD154 monoclonal antibody): third generation monoclonal antibody as a potential first line monotherapy for preventing or treating ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up